MedTrace Logo

Defining the Normal Human Response to Probiotics

NCT03140878 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2018-04-23

No results posted yet for this study

Summary

The study is a mono-center, randomized, semi-blinded, placebo-controlled, cross-over, proof-of principle study in healthy volunteers. The study will determine the probiotic effect of LGG on intestinal tissue and intestinal cells

Conditions

  • Healthy Response to Probiotics

Interventions

DIETARY_SUPPLEMENT

LGG

LGG is dissolved in water and consumed at one occasion (either at visit 2 or 3)

DIETARY_SUPPLEMENT

Placebo

Placebo is dissolved in water and consumed at one occasion (either at visit 2 or 3)

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Chr Hansen

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-16
Primary Completion
2017-06-11
Completion
2017-06-11

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03140878 on ClinicalTrials.gov